(UNH) UnitedHealth - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US91324P1021

UNH EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of UNH over the last 5 years for every Quarter.

UNH Revenue

This chart shows the Revenue of UNH over the last 5 years for every Quarter.

UNH: Health Insurance, Healthcare Services, Pharmacy Services, Healthcare Technology

UnitedHealth Group Incorporated is a diversified healthcare conglomerate operating in the United States and internationally, leveraging its four primary segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. UnitedHealthcare provides a broad range of health benefit plans and services to various customer segments, including national employers, individuals, and state programs. Optum Health focuses on care delivery, management, and wellness services, while Optum Insight offers technology and data analytics solutions to healthcare stakeholders. Optum Rx provides comprehensive pharmacy care services, including retail, specialty, and home delivery pharmacy services.

The companys diversified business model enables it to capitalize on various trends in the healthcare industry, including the growing demand for managed care, the increasing importance of data analytics in healthcare, and the need for efficient pharmacy care services. With a strong presence in the US healthcare market, UnitedHealth Group is well-positioned to benefit from the ongoing shift towards value-based care and the growing focus on healthcare technology.

From a technical analysis perspective, the current price of UNH is 301.91, significantly below its 52-week high of 620.21 and its 200-day moving average of 519.69. The stock is currently testing the support level at 298.6, with a potential downside risk to 200.0 if the support is breached. However, if the support holds, the stock may experience a bounce, potentially targeting the resistance level at 322.8. Given the current ATR of 20.52 (6.80%), the stock is likely to experience significant price movements in the short term.

Combining the technical analysis with fundamental data, we can forecast that UNH may experience a short-term correction due to its oversold condition, as indicated by the RSI not being provided but inferable from the significant drop from its 52W High. However, the companys strong fundamentals, including a P/E ratio of 12.49 and a RoE of 24.09, suggest that the stock may be undervalued in the long term. As the healthcare industry continues to evolve, UnitedHealth Groups diversified business model and strong market presence position it for long-term growth, potentially driving the stock price higher. A potential forecast is that UNH may stabilize around the 298.6 support level and then gradually recover, potentially reaching the 322.8 resistance level in the short term, and higher in the long term as the companys fundamentals continue to drive growth.

Additional Sources for UNH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

UNH Stock Overview

Market Cap in USD 272,487m
Sector Healthcare
Industry Healthcare Plans
GiC Sub-Industry Managed Health Care
IPO / Inception 1984-10-26

UNH Stock Ratings

Growth Rating 18.6
Fundamental 71.8
Dividend Rating 66.6
Rel. Strength -32.4
Analysts 4.15 of 5
Fair Price Momentum 262.04 USD
Fair Price DCF 587.97 USD

UNH Dividends

Dividend Yield 12m 1.99%
Yield on Cost 5y 3.16%
Annual Growth 5y 11.11%
Payout Consistency 95.3%
Payout Ratio 30.4%

UNH Growth Ratios

Growth Correlation 3m -84.5%
Growth Correlation 12m -52.3%
Growth Correlation 5y 71.9%
CAGR 5y 3.34%
CAGR/Max DD 5y 0.06
Sharpe Ratio 12m 0.09
Alpha -42.69
Beta 0.351
Volatility 26.63%
Current Volume 12096.2k
Average Volume 20d 16188.3k
What is the price of UNH shares?
As of June 15, 2025, the stock is trading at USD 313.53 with a total of 12,096,235 shares traded.
Over the past week, the price has changed by +3.40%, over one month by +0.69%, over three months by -34.89% and over the past year by -35.95%.
Is UnitedHealth a good stock to buy?
Yes, based on ValueRay´s Fundamental Analyses, UnitedHealth (NYSE:UNH) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 71.78 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UNH is around 262.04 USD . This means that UNH is currently overvalued and has a potential downside of -16.42%.
Is UNH a buy, sell or hold?
UnitedHealth has received a consensus analysts rating of 4.15. Therefor, it is recommend to buy UNH.
  • Strong Buy: 14
  • Buy: 6
  • Hold: 5
  • Sell: 1
  • Strong Sell: 1
What are the forecasts for UNH share price target?
According to our own proprietary Forecast Model, UNH UnitedHealth will be worth about 285 in June 2026. The stock is currently trading at 313.53. This means that the stock has a potential downside of -9.12%.
Issuer Target Up/Down from current
Wallstreet Target Price 388.3 23.9%
Analysts Target Price 397.4 26.7%
ValueRay Target Price 285 -9.1%